Topical corticosteroids early in bacterial keratitis may improve vision

Article

Research from the University of California, San Francisco, found that adding topical corticosteroids two to three days after starting topical antibiotics for the treatment of bacterial keratitis is linked to improved vision, according to a study recently published in JAMA Ophthalmology.

San Francisco-Research from the University of California, San Francisco, found that adding topical corticosteroids two to three days after starting topical antibiotics for the treatment of bacterial keratitis is linked to improved vision, according to a study recently published in JAMA Ophthalmology

The study assessed the timing of the administration of corticosteroids in a subgroup analysis of the Steroids for Corneal Ulcers Trial (SCUT), a randomized, double-masked, placebo-controlled trial that overall found no effect of adding topical corticosteroids to topical moxifloxacin hydrochloride in bacterial keratitis.

The researchers assessed the effect of topical corticosteroids (vs. placebo) on three-month best spectacle-corrected visual acuity in patients who received the treatment or placebo earlier (two to three days after starting topical antibiotics) vs. later (four days or later after starting topical antibiotics). The group also analyzed subgroups of patients with non-Nocardia keratitis and those with no topical antibiotic use before enrollment.

The patients who received the topical corticosteroids earlier had approximately one-line better visual acuity at three months than those given the placebo. In patients who were given the topical corticosteroids later had one-line worse visual acuity at three months compared to those in the placebo group.

The study states, “There may be a benefit with adjunctive topical corticosteroids if application occurs earlier in the course of bacterial corneal ulcers.”

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Selina McGee, OD, shares what she wants to see in future State of Dry Eye surveys and how this year's results will affect her patient care.
Marc Bloomenstein, OD, FAAO, is a clinical investigator in the trials and overviews the transformative potential of LNZ100.
Shawn Hobbs, OD, previews the annual NOA convention, which takes place in Columbus, Ohio, from July 10 to 12, 2025.
Clark Chang, OD, MSA, MSc, FAAO, gave a presentation alongside Susan Gromacki, OD, MS, FAAO, FSLS, at this year's Optometry's Meeting.
Selina McGee, OD, FAAO, Dipl ABO, shares key takeaways and a personal anecdote relating to the State of Dry Eye survey results.
Devin Sasser, OD, shares his excitement for Acuvue Oasys MAX 1-Day multifocal for astigmatism, the first and only daily disposable multifocal toric contact lens.
Reviewing the State of Dry Eye Survey with Selina McGee, OD, FAAO, Dipl ABO.
Jessilin Quint, OD, MBA, FAAO, outlines her AOA's Optometry's Meeting 2025 presentation on nutrition and its impact on ocular health.
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
© 2025 MJH Life Sciences

All rights reserved.